EP3727365A4 - Modified release formulations of flurbiprofen - Google Patents

Modified release formulations of flurbiprofen Download PDF

Info

Publication number
EP3727365A4
EP3727365A4 EP18916470.0A EP18916470A EP3727365A4 EP 3727365 A4 EP3727365 A4 EP 3727365A4 EP 18916470 A EP18916470 A EP 18916470A EP 3727365 A4 EP3727365 A4 EP 3727365A4
Authority
EP
European Patent Office
Prior art keywords
flurbiprofen
release formulations
modified release
modified
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18916470.0A
Other languages
German (de)
French (fr)
Other versions
EP3727365A2 (en
Inventor
Ali TÜRKYILMAZ
Nur PEHLIVAN AKALIN
Kerim AKKAYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3727365A2 publication Critical patent/EP3727365A2/en
Publication of EP3727365A4 publication Critical patent/EP3727365A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
EP18916470.0A 2017-12-21 2018-12-20 Modified release formulations of flurbiprofen Pending EP3727365A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/21036A TR201721036A2 (en) 2017-12-21 2017-12-21 MODULATED EMISSION FORMULATIONS OF FLURBIPROPHEN
PCT/TR2018/050846 WO2019209217A2 (en) 2017-12-21 2018-12-20 Modified release formulations of flurbiprofen

Publications (2)

Publication Number Publication Date
EP3727365A2 EP3727365A2 (en) 2020-10-28
EP3727365A4 true EP3727365A4 (en) 2021-06-16

Family

ID=67901210

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18916470.0A Pending EP3727365A4 (en) 2017-12-21 2018-12-20 Modified release formulations of flurbiprofen

Country Status (3)

Country Link
EP (1) EP3727365A4 (en)
TR (1) TR201721036A2 (en)
WO (1) WO2019209217A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023244502A1 (en) * 2022-06-13 2023-12-21 Soin Therapeutics Llc Methods of using low dose naltrexone to treat chronic pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010771A1 (en) * 1991-12-05 1993-06-10 Alfatec-Pharma Gmbh Slow-release flurbiprofen-containing medicament and its use
US5556638A (en) * 1991-12-05 1996-09-17 Alfatec Pharma Gmbh Flurbiprofen-containing immediate-effect medicament and its use
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190418B1 (en) * 2007-08-15 2013-10-02 Mcneil-PPC, Inc Immediate release and sustained release ibuprofen dosing regimen
CA2965237C (en) * 2014-10-21 2023-11-21 Reckitt Benckiser Llc Pharmaceutical capsule containing at least two tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010771A1 (en) * 1991-12-05 1993-06-10 Alfatec-Pharma Gmbh Slow-release flurbiprofen-containing medicament and its use
US5556638A (en) * 1991-12-05 1996-09-17 Alfatec Pharma Gmbh Flurbiprofen-containing immediate-effect medicament and its use
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAVIES NEAL M.: "Clinical Pharmacokinetics of Flurbiprofen and its Enantiomers :", CLINICAL PHARMACOKINETICS., vol. 28, no. 2, 1 February 1995 (1995-02-01), NZ, pages 100 - 114, XP055801584, ISSN: 0312-5963, Retrieved from the Internet <URL:http://dx.doi.org/10.2165/00003088-199528020-00002> DOI: 10.2165/00003088-199528020-00002 *
See also references of WO2019209217A2 *

Also Published As

Publication number Publication date
EP3727365A2 (en) 2020-10-28
WO2019209217A3 (en) 2020-01-23
TR201721036A2 (en) 2019-07-22
WO2019209217A2 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
EP3582755A4 (en) Formulations
IL280485A (en) Modified release formulations of pridopidine
EP3509581A4 (en) Formulations of (r
EP3371152A4 (en) Compositions comprising an inhibitor of lysine specific demethylase-1
EP3099381A4 (en) Extended release fragrance compositions
EP3054929A4 (en) Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP3484456A4 (en) Extended release dosage forms of pregabalin
EP3291800A4 (en) Sprinkle formulations of acamprosate
EP4072553A4 (en) Cariprazine release formulations
EP3512521A4 (en) Extended release pharmaceutical composition of clozapine
EP3600279A4 (en) 1-amino-1-cyclopropanecaboxylic acid formulations
EP3265066A4 (en) Immediate release soluble ibuprofen compositions
IL272857A (en) Formulations of copanlisib
EP3402463A4 (en) Formulations of vancomycin
EP3711763A4 (en) Controlled release formulation
EP3490530A4 (en) Slow release composition of active ingredients
EP3261625A4 (en) Tripulse release stimulant formulations
EP3716766A4 (en) Benzoxaborole compounds and formulations thereof
EP3722372A4 (en) Curable silicone release agent composition
EP3426238A4 (en) Curcumin-based compositions&amp;methods of use thereof
EP3727365A4 (en) Modified release formulations of flurbiprofen
EP3554508A4 (en) Pharmaceutical formulations of suvorexant
EP3373907A4 (en) Sustained release pharmaceutical compositions and methods of use
PT3678644T (en) Formulations of copanlisib
EP3355863A4 (en) Stable formulations of fingolimod

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200718

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210514

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/192 20060101AFI20210508BHEP

Ipc: A61K 9/48 20060101ALI20210508BHEP

Ipc: A61K 9/50 20060101ALI20210508BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230629

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708